| N6D | Name: | N-[3-(methoxymethyl)phenyl]-N'-(5-methyl-1,2-oxazol-3-yl)urea | Formula: | C13 H15 N3 O3 | SMILES: | N(C(Nc1cccc(COC)c1)=O)c2cc(C)on2 | InChi: | InChI=1S/C13H15N3O3/c1-9-6-12(16-19-9)15-13(17)14-11-5-3-4-10(7-11)8-18-2/h3-7H,8H2,1-2H3,(H2,14,15,16,17) | Definition date: | 2019-05-03 | Last modified: | 2019-12-13 | Release date: | 2019-12-18 | Identifier: | N-[3-(methoxymethyl)phenyl]-N'-(5-methyl-1,2-oxazol-3-yl)urea |
|
| N6J | Name: | N-{1-[(imidazo[1,2-a]pyridin-2-yl)methyl]-1H-pyrazol-4-yl}-N'-(5-methyl-1,2-oxazol-3-yl)urea | Formula: | C16 H15 N7 O2 | SMILES: | N(c3cnn(Cc2cn1ccccc1n2)c3)C(Nc4cc(C)on4)=O | InChi: | InChI=1S/C16H15N7O2/c1-11-6-14(21-25-11)20-16(24)19-12-7-17-23(9-12)10-13-8-22-5-3-2-4-15(22)18-13/h2-9H,10H2,1H3,(H2,19,20,21,24) | Definition date: | 2019-05-03 | Last modified: | 2019-12-13 | Release date: | 2019-12-18 | Identifier: | N-{1-[(imidazo[1,2-a]pyridin-2-yl)methyl]-1H-pyrazol-4-yl}-N'-(5-methyl-1,2-oxazol-3-yl)urea |
|
| N6V | Name: | N-{1-[2-(diethylamino)ethyl]-1H-indol-5-yl}-N'-(5-methyl-1,2-oxazol-3-yl)urea | Formula: | C19 H25 N5 O2 | SMILES: | n1(CCN(CC)CC)ccc2c1ccc(c2)NC(Nc3cc(C)on3)=O | InChi: | InChI=1S/C19H25N5O2/c1-4-23(5-2)10-11-24-9-8-15-13-16(6-7-17(15)24)20-19(25)21-18-12-14(3)26-22-18/h6-9,12-13H,4-5,10-11H2,1-3H3,(H2,20,21,22,25) | Definition date: | 2019-05-03 | Last modified: | 2019-12-13 | Release date: | 2019-12-18 | Identifier: | N-{1-[2-(diethylamino)ethyl]-1H-indol-5-yl}-N'-(5-methyl-1,2-oxazol-3-yl)urea |
|
| N71 | Name: | N-(5-methyl-1,2-oxazol-3-yl)-N'-[2-(phenylsulfonyl)ethyl]urea | Formula: | C13 H15 N3 O4 S | SMILES: | N(CCS(c1ccccc1)(=O)=O)C(Nc2cc(C)on2)=O | InChi: | InChI=1S/C13H15N3O4S/c1-10-9-12(16-20-10)15-13(17)14-7-8-21(18,19)11-5-3-2-4-6-11/h2-6,9H,7-8H2,1H3,(H2,14,15,16,17) | Definition date: | 2019-05-03 | Last modified: | 2019-12-13 | Release date: | 2019-12-18 | Identifier: | N-(5-methyl-1,2-oxazol-3-yl)-N'-[2-(phenylsulfonyl)ethyl]urea |
|
| N74 | Name: | N-(1-benzyl-1H-pyrazol-4-yl)-N'-(5-methyl-1,2-oxazol-3-yl)urea | Formula: | C15 H15 N5 O2 | SMILES: | N(c2cnn(Cc1ccccc1)c2)C(Nc3cc(C)on3)=O | InChi: | InChI=1S/C15H15N5O2/c1-11-7-14(19-22-11)18-15(21)17-13-8-16-20(10-13)9-12-5-3-2-4-6-12/h2-8,10H,9H2,1H3,(H2,17,18,19,21) | Definition date: | 2019-05-03 | Last modified: | 2019-12-13 | Release date: | 2019-12-18 | Identifier: | N-(1-benzyl-1H-pyrazol-4-yl)-N'-(5-methyl-1,2-oxazol-3-yl)urea |
|
| NJZ | Name: | [3-bromanyl-5-(carbamimidoylsulfanylmethyl)phenyl]methyl carbamimidothioate | Formula: | C10 H13 Br N4 S2 | SMILES: | NC(=N)SCc1cc(Br)cc(CSC(N)=N)c1 | InChi: | InChI=1S/C10H13BrN4S2/c11-8-2-6(4-16-9(12)13)1-7(3-8)5-17-10(14)15/h1-3H,4-5H2,(H3,12,13)(H3,14,15) | Definition date: | 2019-12-02 | Last modified: | 2019-12-13 | Release date: | 2019-12-18 | Identifier: | [3-bromanyl-5-(carbamimidoylsulfanylmethyl)phenyl]methyl carbamimidothioate |
|
| NK5 | Name: | ~{N}-oxidanyl-1-phenyl-1,2,3-triazole-4-carboxamide | Formula: | C9 H8 N4 O2 | SMILES: | ONC(=O)c1cn(nn1)c2ccccc2 | InChi: | InChI=1S/C9H8N4O2/c14-9(11-15)8-6-13(12-10-8)7-4-2-1-3-5-7/h1-6,15H,(H,11,14) | Definition date: | 2019-12-03 | Last modified: | 2019-12-13 | Release date: | 2019-12-18 | Identifier: | ~{N}-oxidanyl-1-phenyl-1,2,3-triazole-4-carboxamide |
|
| NO5 | Name: | (2~{S})-3-methyl-2-(sulfamoylamino)butanoic acid | Formula: | C5 H12 N2 O4 S | SMILES: | CC(C)[CH](N[S](N)(=O)=O)C(O)=O | InChi: | InChI=1S/C5H12N2O4S/c1-3(2)4(5(8)9)7-12(6,10)11/h3-4,7H,1-2H3,(H,8,9)(H2,6,10,11)/t4-/m0/s1 | Definition date: | 2019-12-09 | Last modified: | 2019-12-13 | Release date: | 2019-12-18 | Identifier: | (2~{S})-3-methyl-2-(sulfamoylamino)butanoic acid |
|
| NQ1 | Name: | 10-benzyl-8-fluoro-5,10-dihydro-11H-dibenzo[b,e][1,4]diazepin-11-one | Formula: | C20 H15 F N2 O | SMILES: | c32C(N(c1cc(F)ccc1Nc2cccc3)Cc4ccccc4)=O | InChi: | InChI=1S/C20H15FN2O/c21-15-10-11-18-19(12-15)23(13-14-6-2-1-3-7-14)20(24)16-8-4-5-9-17(16)22-18/h1-12,22H,13H2 | Definition date: | 2019-05-23 | Last modified: | 2019-12-13 | Release date: | 2019-12-18 | Identifier: | 10-benzyl-8-fluoro-5,10-dihydro-11H-dibenzo[b,e][1,4]diazepin-11-one |
|
| O57 | Name: | 10-benzyl-2-fluoro-5,10-dihydro-11H-dibenzo[b,e][1,4]diazepin-11-one | Formula: | C20 H15 F N2 O | SMILES: | c1ccc(cc1)CN4C(c2cc(ccc2Nc3ccccc34)F)=O | InChi: | InChI=1S/C20H15FN2O/c21-15-10-11-17-16(12-15)20(24)23(13-14-6-2-1-3-7-14)19-9-5-4-8-18(19)22-17/h1-12,22H,13H2 | Definition date: | 2019-06-11 | Last modified: | 2019-12-13 | Release date: | 2019-12-18 | Identifier: | 10-benzyl-2-fluoro-5,10-dihydro-11H-dibenzo[b,e][1,4]diazepin-11-one |
|
| OP4 | Name: | 5-fluoro-2-({4-[7-({trans-4-[(methylsulfonyl)amino]cyclohexyl}methyl)-2,7-diazaspiro[3.5]nonan-2-yl]pyrimidin-5-yl}oxy)-N,N-di(propan-2-yl)benzamide | Formula: | C32 H47 F N6 O4 S | SMILES: | Fc1ccc(c(c1)C(=O)N(C(C)C)C(C)C)Oc5c(N2CC3(C2)CCN(CC3)CC4CCC(CC4)NS(=O)(C)=O)ncnc5 | InChi: | InChI=1S/C32H47FN6O4S/c1-22(2)39(23(3)4)31(40)27-16-25(33)8-11-28(27)43-29-17-34-21-35-30(29)38-19-32(20-38)12-14-37(15-13-32)18-24-6-9-26(10-7-24)36-44(5,41)42/h8,11,16-17,21-24,26,36H,6-7,9-10,12-15,18-20H2,1-5H3/t24-,26- | Definition date: | 2019-07-02 | Last modified: | 2019-12-13 | Release date: | 2019-12-18 | Identifier: | 5-fluoro-2-({4-[7-({trans-4-[(methylsulfonyl)amino]cyclohexyl}methyl)-2,7-diazaspiro[3.5]nonan-2-yl]pyrimidin-5-yl}oxy)-N,N-di(propan-2-yl)benzamide |
|
| BQX | Name: | 1-[4-(6-aminopurin-9-yl)butylsulfamoyl]-3-[4-[(4~{S})-2-oxidanylidene-1,3,3~{a},4,6,6~{a}-hexahydrothieno[3,4-d]imidazol-4-yl]butyl]urea | Formula: | C19 H30 N10 O4 S2 | SMILES: | Nc1ncnc2n(CCCCN[S](=O)(=O)NC(=O)NCCCC[CH]3SC[CH]4NC(=O)N[CH]34)cnc12 | InChi: | InChI=1S/C19H30N10O4S2/c20-16-15-17(23-10-22-16)29(11-24-15)8-4-3-7-25-35(32,33)28-18(30)21-6-2-1-5-13-14-12(9-34-13)26-19(31)27-14/h10-14,25H,1-9H2,(H2,20,22,23)(H2,21,28,30)(H2,26,27,31)/t12-,13-,14-/m0/s1 | Definition date: | 2018-12-17 | Last modified: | 2019-12-13 | Release date: | 2019-12-18 | Identifier: | 1-[4-(6-aminopurin-9-yl)butylsulfamoyl]-3-[4-[(4~{S})-2-oxidanylidene-1,3,3~{a},4,6,6~{a}-hexahydrothieno[3,4-d]imidazol-4-yl]butyl]urea |
|
| PX7 | Name: | 4-methyl-1lambda~6~,2,4-benzothiadiazine-1,1,3(2H,4H)-trione | Formula: | C8 H8 N2 O3 S | SMILES: | N2S(c1ccccc1N(C2=O)C)(=O)=O | InChi: | InChI=1S/C8H8N2O3S/c1-10-6-4-2-3-5-7(6)14(12,13)9-8(10)11/h2-5H,1H3,(H,9,11) | Definition date: | 2019-08-28 | Last modified: | 2019-12-13 | Release date: | 2019-12-18 | Identifier: | 4-methyl-1lambda~6~,2,4-benzothiadiazine-1,1,3(2H,4H)-trione |
|
| Q5J | Name: | 4-(aminomethyl)-N-(3-cyano-4-methyl-1H-indol-7-yl)benzene-1-sulfonamide | Formula: | C17 H16 N4 O2 S | SMILES: | c1c(c3c(c(c1)NS(=O)(=O)c2ccc(cc2)CN)ncc3C#N)C | InChi: | InChI=1S/C17H16N4O2S/c1-11-2-7-15(17-16(11)13(9-19)10-20-17)21-24(22,23)14-5-3-12(8-18)4-6-14/h2-7,10,20-21H,8,18H2,1H3 | Definition date: | 2019-09-23 | Last modified: | 2019-12-13 | Release date: | 2019-12-18 | Identifier: | 4-(aminomethyl)-N-(3-cyano-4-methyl-1H-indol-7-yl)benzene-1-sulfonamide |
|
| Q5V | Name: | N-[(4-methoxyphenyl)sulfonyl]-N-(4-{[(4-methoxyphenyl)sulfonyl](2,2,2-trifluoroethyl)amino}isoquinolin-1-yl)glycine | Formula: | C27 H24 F3 N3 O8 S2 | SMILES: | c1c(ccc(c1)OC)S(=O)(=O)N(CC(O)=O)c3ncc(N(S(=O)(c2ccc(OC)cc2)=O)CC(F)(F)F)c4c3cccc4 | InChi: | InChI=1S/C27H24F3N3O8S2/c1-40-18-7-11-20(12-8-18)42(36,37)32(16-25(34)35)26-23-6-4-3-5-22(23)24(15-31-26)33(17-27(28,29)30)43(38,39)21-13-9-19(41-2)10-14-21/h3-15H,16-17H2,1-2H3,(H,34,35) | Definition date: | 2019-09-24 | Last modified: | 2019-12-13 | Release date: | 2019-12-18 | Identifier: | N-[(4-methoxyphenyl)sulfonyl]-N-(4-{[(4-methoxyphenyl)sulfonyl](2,2,2-trifluoroethyl)amino}isoquinolin-1-yl)glycine |
|
| Q5Y | Name: | N-[(4-methoxyphenyl)sulfonyl]-N-(4-{[(4-methoxyphenyl)sulfonyl]amino}naphthalen-1-yl)glycine | Formula: | C26 H24 N2 O8 S2 | SMILES: | O(C)c4ccc(S(=O)(=O)N(c1c3c(c(cc1)NS(=O)(=O)c2ccc(cc2)OC)cccc3)CC(O)=O)cc4 | InChi: | InChI=1S/C26H24N2O8S2/c1-35-18-7-11-20(12-8-18)37(31,32)27-24-15-16-25(23-6-4-3-5-22(23)24)28(17-26(29)30)38(33,34)21-13-9-19(36-2)10-14-21/h3-16,27H,17H2,1-2H3,(H,29,30) | Definition date: | 2019-09-24 | Last modified: | 2019-12-13 | Release date: | 2019-12-18 | Identifier: | N-[(4-methoxyphenyl)sulfonyl]-N-(4-{[(4-methoxyphenyl)sulfonyl]amino}naphthalen-1-yl)glycine |
|
| Q61 | Name: | guanosine-5'-monophosphate-2',3'-vanadate | Formula: | C10 H12 N5 O10 P V | SMILES: | C3(n2c1N=C(N)NC(c1nc2)=O)OC(C4C3O[V](=O)(O)O4)COP(=O)(O)O | InChi: | InChI=1S/C10H12N5O8P.H2O.O.V/c11-10-13-7-4(8(18)14-10)12-2-15(7)9-6(17)5(16)3(23-9)1-22-24(19,20)21 | Definition date: | 2019-09-24 | Last modified: | 2019-12-13 | Release date: | 2019-12-18 | Identifier: | [5'-guanylato(2-)-kappa~2~O~2'~,O~3'~](hydroxy)oxovanadium |
|
| Q71 | Name: | 7-fluoro-1lambda~6~,2,4-benzothiadiazine-1,1,3(2H,4H)-trione | Formula: | C7 H5 F N2 O3 S | SMILES: | c1(F)cc2c(cc1)NC(NS2(=O)=O)=O | InChi: | InChI=1S/C7H5FN2O3S/c8-4-1-2-5-6(3-4)14(12,13)10-7(11)9-5/h1-3H,(H2,9,10,11) | Definition date: | 2019-09-27 | Last modified: | 2019-12-13 | Release date: | 2019-12-18 | Identifier: | 7-fluoro-1lambda~6~,2,4-benzothiadiazine-1,1,3(2H,4H)-trione |
|
| Q77 | Name: | 5,7-dimethyl-1lambda~6~,2,4-benzothiadiazine-1,1,3(2H,4H)-trione | Formula: | C9 H10 N2 O3 S | SMILES: | Cc1cc2c(c(C)c1)NC(NS2(=O)=O)=O | InChi: | InChI=1S/C9H10N2O3S/c1-5-3-6(2)8-7(4-5)15(13,14)11-9(12)10-8/h3-4H,1-2H3,(H2,10,11,12) | Definition date: | 2019-09-27 | Last modified: | 2019-12-13 | Release date: | 2019-12-18 | Identifier: | 5,7-dimethyl-1lambda~6~,2,4-benzothiadiazine-1,1,3(2H,4H)-trione |
|
| Q7A | Name: | 5-chloro-1lambda~6~,2,4-benzothiadiazine-1,1,3(2H,4H)-trione | Formula: | C7 H5 Cl N2 O3 S | SMILES: | O=C2NS(=O)(=O)c1c(c(ccc1)Cl)N2 | InChi: | InChI=1S/C7H5ClN2O3S/c8-4-2-1-3-5-6(4)9-7(11)10-14(5,12)13/h1-3H,(H2,9,10,11) | Definition date: | 2019-09-27 | Last modified: | 2019-12-13 | Release date: | 2019-12-18 | Identifier: | 5-chloro-1lambda~6~,2,4-benzothiadiazine-1,1,3(2H,4H)-trione |
|
| QPD | Name: | (2R)-2-[2-(1H-indole-3-carbonyl)hydrazinyl]-2-phenylacetamide | Formula: | C17 H16 N4 O2 | SMILES: | c2ccc3ncc(C(=O)NNC(c1ccccc1)C(=O)N)c3c2 | InChi: | InChI=1S/C17H16N4O2/c18-16(22)15(11-6-2-1-3-7-11)20-21-17(23)13-10-19-14-9-5-4-8-12(13)14/h1-10,15,19-20H,(H2,18,22)(H,21,23)/t15-/m1/s1 | Definition date: | 2019-12-05 | Last modified: | 2019-12-13 | Release date: | 2019-12-18 | Identifier: | (2R)-2-[2-(1H-indole-3-carbonyl)hydrazinyl]-2-phenylacetamide |
|
| DZR | Name: | ~{N}-[[1-[2-(~{tert}-butylamino)-2-oxidanylidene-ethyl]piperidin-4-yl]methyl]-3-chloranyl-5-fluoranyl-benzamide | Formula: | C19 H27 Cl F N3 O2 | SMILES: | CC(C)(C)NC(=O)CN1CCC(CC1)CNC(=O)c2cc(F)cc(Cl)c2 | InChi: | InChI=1S/C19H27ClFN3O2/c1-19(2,3)23-17(25)12-24-6-4-13(5-7-24)11-22-18(26)14-8-15(20)10-16(21)9-14/h8-10,13H,4-7,11-12H2,1-3H3,(H,22,26)(H,23,25) | Definition date: | 2019-09-26 | Last modified: | 2019-12-13 | Release date: | 2019-12-18 | Identifier: | ~{N}-[[1-[2-(~{tert}-butylamino)-2-oxidanylidene-ethyl]piperidin-4-yl]methyl]-3-chloranyl-5-fluoranyl-benzamide |
|
| EA3 | Name: | 4-chloranyl-2-cyclohexylsulfanyl-~{N}-(2-hydroxyethyl)-5-sulfamoyl-benzamide | Formula: | C15 H21 Cl N2 O4 S2 | SMILES: | N[S](=O)(=O)c1cc(C(=O)NCCO)c(SC2CCCCC2)cc1Cl | InChi: | InChI=1S/C15H21ClN2O4S2/c16-12-9-13(23-10-4-2-1-3-5-10)11(15(20)18-6-7-19)8-14(12)24(17,21)22/h8-10,19H,1-7H2,(H,18,20)(H2,17,21,22) | Definition date: | 2019-03-27 | Last modified: | 2019-12-13 | Release date: | 2019-12-18 | Identifier: | 4-chloranyl-2-cyclohexylsulfanyl-~{N}-(2-hydroxyethyl)-5-sulfamoyl-benzamide |
|
| 4I7 | Name: | (4~{a}~{S},8~{a}~{R})-4-[4-methoxy-3-[[2-(trifluoromethyl)phenyl]methoxy]phenyl]-2-(1-thieno[3,2-d]pyrimidin-4-ylpiperidin-4-yl)-4~{a},5,8,8~{a}-tetrahydrophthalazin-1-one | Formula: | C34 H32 F3 N5 O3 S | SMILES: | COc1ccc(cc1OCc2ccccc2C(F)(F)F)C3=NN(C4CCN(CC4)c5ncnc6ccsc56)C(=O)[CH]7CC=CC[CH]37 | InChi: | InChI=1S/C34H32F3N5O3S/c1-44-28-11-10-21(18-29(28)45-19-22-6-2-5-9-26(22)34(35,36)37)30-24-7-3-4-8-25(24)33(43)42(40-30)23-12-15-41(16-13-23)32-31-27(14-17-46-31)38-20-39-32/h2-6,9-11,14,17-18,20,23-25H,7-8,12-13,15-16,19H2,1H3/t24-,25+/m0/s1 | Definition date: | 2018-11-29 | Last modified: | 2019-12-13 | Release date: | 2019-12-18 | Identifier: | (4~{a}~{S},8~{a}~{R})-4-[4-methoxy-3-[[2-(trifluoromethyl)phenyl]methoxy]phenyl]-2-(1-thieno[3,2-d]pyrimidin-4-ylpiperidin-4-yl)-4~{a},5,8,8~{a}-tetrahydrophthalazin-1-one |
|
| G5H | Name: | 5'-O-(N-(L-aspartyl)-sulfamoyl)uridine | Formula: | C13 H18 N4 O11 S | SMILES: | N[CH](CC(O)=O)C(=O)N[S](=O)(=O)OC[CH]1O[CH]([CH](O)[CH]1O)N2C=CC(=O)NC2=O | InChi: | InChI=1S/C13H18N4O11S/c14-5(3-8(19)20)11(23)16-29(25,26)27-4-6-9(21)10(22)12(28-6)17-2-1-7(18)15-13(17)24/h1-2,5-6,9-10,12,21-22H,3-4,14H2,(H,16,23)(H,19,20)(H,15,18,24)/t5-,6+,9+,10+,12+/m0/s1 | Definition date: | 2018-08-29 | Last modified: | 2019-12-13 | Release date: | 2019-12-18 | Identifier: | (3~{S})-3-azanyl-4-[[(2~{R},3~{S},4~{R},5~{R})-5-[2,4-bis(oxidanylidene)pyrimidin-1-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methoxysulfonylamino]-4-oxidanylidene-butanoic acid |
|